Search results
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 21 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 1 day agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 10 hours agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoAs concerns grow about the H5 bird flu, Moderna and fellow Covid jab maker Pfizer say they're ready...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 8 hours agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 6 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 9 hours agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...